Cite
Huang BJ, Smith JL, Wang YC, et al. CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Blood Adv. 2021;5(23):4963-4968doi: 10.1182/bloodadvances.2021004965.
Huang, B. J., Smith, J. L., Wang, Y. C., Taghizadeh, K., Leonti, A. R., Ries, R. E., Liu, Y., Kolekar, P., Tarlock, K., Gerbing, R., Crowgey, E., Furlan, S. N., Shaw, T. I., Hagiwara, K., Wei, L., Cooper, T. M., Gamis, A. S., Aplenc, R., Kolb, E. A., Farrar, J. E., Triche, T., Alonzo, T. A., Ma, X., & Meshinchi, S. (2021). CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Blood advances, 5(23), 4963-4968. https://doi.org/10.1182/bloodadvances.2021004965
Huang, Benjamin J, et al. "CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes." Blood advances vol. 5,23 (2021): 4963-4968. doi: https://doi.org/10.1182/bloodadvances.2021004965
Huang BJ, Smith JL, Wang YC, Taghizadeh K, Leonti AR, Ries RE, Liu Y, Kolekar P, Tarlock K, Gerbing R, Crowgey E, Furlan SN, Shaw TI, Hagiwara K, Wei L, Cooper TM, Gamis AS, Aplenc R, Kolb EA, Farrar JE, Triche T, Alonzo TA, Ma X, Meshinchi S. CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes. Blood Adv. 2021 Dec 14;5(23):4963-4968. doi: 10.1182/bloodadvances.2021004965. PMID: 34547772.
Copy
Download .nbib